VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker

International Journal of Oncology

Volumn 34, Issue 3, 2009, Pages 673-680

  Sugiura, Tsuyoshi ^a   Inoue, Yoshiko ^a   Matsuki, Ryosuke ^a   Ishii, Kotaro ^a   Takahashi, Miho ^a   Abe, Masakazu ^a   Shirasuna, Kanemitsu ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Lymph node metastasis; Lymphatic vessel density; Oral squamous cell carcinoma; VEGF C; VEGF D

Indexed keywords

VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENSITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL BIOPSY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASMS, SQUAMOUS CELL; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 64549103445     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000193     Document Type: Article

References (29)

1. Zeng Y, Opeskin K, Horvath LG, Sutherland RL and Williams ED: Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 65: 222-230, 2005.
2. Hall FT, Freeman JL, Asa SL, Jackson DG and Beasley NJ: Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 129: 716-719, 2003.
3. Straume O, Jackson DG and Akslen LA: Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9: 250-256, 2003.
4. Jackson DG: New molecular markers for the study of tumor lymphangiogenesis. Anticancer Res 21: 4279-4283, 2001.
5. Roy H, Bhardwaj S and Yla-Herttuala S: Biology of vascular endothelial growth factors. FEBS Lett 580: 2879-2887, 2006.
6. Kitadai Y, Kodama M, Cho S, Kuroda T, Ochiumi T, Kimura S, Tanaka S, Matsumura S, Yasui W and Chayama K: Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer 115: 388-392, 2005.
7. Hermanek P and Sobin LH (eds): UICC: TNM Classification of Malignant Tumors. 4th edition. Springer-Verlag, Berlin, 1987.
8. Wasi PN, Cohen B, Luthra UK and Torloni H: Histological typing of oral and oropharyngeal tumors. In: WHO: International Histological Classification of Tumor, Geneva, 1971.
9. Anneroth G, Batsakis J and Luna M: Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 95: 229-249, 1987.
10. Beasley NJ, Prevo R, Banerji S, Leek RD, Moore J, van Trappen P, Cox G, Harris AL and Jackson DG: Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62: 1315-1320, 2002.
11. Bono P, Wasenius VM, Heikkila P, Lundin J, Jackson DG and Joensuu H: High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clin Cancer Res 10: 7144-7149, 2004.
12. Zeng Y, Opeskin K, Baldwin ME, Horvath LG, Achen MG, Stacker SA, Sutherland RL and Williams ED: Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clin Cncer Res 10: 5137-5144, 2004.
13. Franchi A, Gallo O, Massi D, Baroni G and Santucci M: Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 101: 973-978, 2004.
14. Xuan M, Fang YR, Wato M, Hata S and Tanaka A: Immunohistochemical co-localization of lymphatics and blood vessels in oral squamous cell carcinomas. J Oral Pathol Med 34: 334-339, 2005.
15. Al-Rawi MA, Mansel RE and Jiang WG: Molecular and cellular mechanisms of lymphangiogenesis. Eur J Surg Oncol 31: 117-121, 2005.
16. Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, Taniguchi K, Miwa K, Ohoyama S, Sugiyama K and Sasaki T: Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 5: 1823-1829, 1999.
17. Salven P, Lymboussaki A, Heikkila P, Jaaskela-Saari H, Enholm B, Aase K, von Euler G, Eriksson U, Alitalo K and Joensuu H: Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 153: 103-108, 1998.
18. Bunone G, Vigneri P, Mariani L, Buto S, Collini P, Pilotti S, Pierotti MA and Bongarzone I: Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 155: 1967-1976, 1999.
19. Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K and Koji T: Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 80: 309-313, 1999.
20. Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, Matsutani N, Yasui W and Chayama K: Clinico-pathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer 93: 662-666, 2001.
21. Furudoi A, Tanaka S, Haruma K, Kitadai Y, Yoshihara M, Chayama K and Shimamoto F: Clinical significance of vascular endothelial growth factor-C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology 62: 157-166, 2002.
22. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y and Hirohashi S: Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 6: 2431-2439, 2000.
23. George ML, Tutton MG, Janssen F, Arnaout A, Abulafi AM, Eccles SA and Swift RI: VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 3: 420-427, 2001.
24. Shintani S, Li C, Ishikawa T, Mihara M, Nakashiro K and Hamakawa H: Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma. Oral Oncol 40: 13-20, 2004.
25. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H and Achen MG: VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7: 186-191, 2001.
26. Enholm B, Karpanen T, Jeltsch M, Kubo H, Stenback F, Prevo R, Jackson DG, Yla-Herttuala S and Alitalo K: Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res 88: 623-629, 2001.
27. Kyzas PA, Geleff S, Batistatou A, Agnantis NJ and Stefanou D: Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 206: 170-177, 2005.
28. Min HY, Doyle LV, Vitt CR, Zandonella CL, Stratton-Thomas JR, Shuman MA and Rosenberg S: Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res 56: 2428-2433, 1996.
29. Pepper MS, Ferrara N, Orci L and Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181: 902-906, 1991.